EA201170812A1 - Способы и композиции для применения вакцины против кокцидиоза - Google Patents

Способы и композиции для применения вакцины против кокцидиоза

Info

Publication number
EA201170812A1
EA201170812A1 EA201170812A EA201170812A EA201170812A1 EA 201170812 A1 EA201170812 A1 EA 201170812A1 EA 201170812 A EA201170812 A EA 201170812A EA 201170812 A EA201170812 A EA 201170812A EA 201170812 A1 EA201170812 A1 EA 201170812A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vaccine against
cockdiosis
compositions
methods
signal sequence
Prior art date
Application number
EA201170812A
Other languages
English (en)
Inventor
Майкл Дж. Шеппард
Original Assignee
Вектоджен Пти Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вектоджен Пти Лтд. filed Critical Вектоджен Пти Лтд.
Publication of EA201170812A1 publication Critical patent/EA201170812A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к вакцине против кокцидиоза для защиты домашней птицы против инфекции Eimeria, содержащей рекомбинантный птичий аденовирусный вектор, содержащий в одной рамке считывания (гетерологичный) промотор, связанный с гидрофобной сигнальной последовательностью для заякоривания в мембране или связанный с гидрофобной секреторной сигнальной последовательностью и участком расщепления для секреции; полилинкер для встраивания в рамке считывания ORF антигена Eimeria, такой как полученная из антигенов r56, 82 кДа, и/или TFP250; сигнал полиаденилирования и геном аденовируса птиц.
EA201170812A 2008-12-15 2009-12-14 Способы и композиции для применения вакцины против кокцидиоза EA201170812A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12259608P 2008-12-15 2008-12-15
PCT/AU2009/001615 WO2010068968A1 (en) 2008-12-15 2009-12-14 Methods and compositions for use of a coccidiosis vaccine

Publications (1)

Publication Number Publication Date
EA201170812A1 true EA201170812A1 (ru) 2012-01-30

Family

ID=42240825

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170812A EA201170812A1 (ru) 2008-12-15 2009-12-14 Способы и композиции для применения вакцины против кокцидиоза

Country Status (16)

Country Link
US (1) US20100150958A1 (ru)
EP (1) EP2376640A1 (ru)
JP (1) JP2013513548A (ru)
KR (1) KR20110132316A (ru)
CN (1) CN102333877A (ru)
AR (1) AR074679A1 (ru)
AU (1) AU2009328621A1 (ru)
BR (1) BRPI0923513A2 (ru)
CA (1) CA2746310A1 (ru)
EA (1) EA201170812A1 (ru)
HR (1) HRP20110484A2 (ru)
IL (1) IL213061A0 (ru)
MX (1) MX2011006409A (ru)
SG (1) SG172184A1 (ru)
TW (1) TW201026322A (ru)
WO (1) WO2010068968A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3097926T3 (pl) * 2007-11-01 2020-04-30 The Board Of Trustees Of The University Of Arkansas Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria
MX2013010620A (es) 2011-03-16 2013-12-06 Univ Guelph Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
WO2014079878A1 (en) * 2012-11-21 2014-05-30 Merz Pharma Gmbh & Co. Kgaa Means and methods for determination of botulinum neurotoxin biological activity
SG11201506398SA (en) 2013-02-14 2015-09-29 Univ Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
CN103251938B (zh) * 2013-04-15 2015-07-15 内蒙古神元生物工程股份有限公司 鸡艾美耳球虫弱毒疫苗产业化生产工艺
KR20170008850A (ko) 2014-05-23 2017-01-24 피브로-애니멀 헬스 코포레이션 배합물, 조성물, 및 배합물 또는 조성물의 동물로의 투여 방법
CN104561047A (zh) * 2014-12-18 2015-04-29 扬州大学 毒害艾美耳球虫配子体抗原Engam59基因及其应用
US10285382B2 (en) 2017-01-09 2019-05-14 Synexis Llc Application of dry hydrogen peroxide (DHP) gas to methods of poultry production
USD890898S1 (en) 2018-01-09 2020-07-21 Synexis Llc Device for producing non-hydrated purified hydrogen peroxide gas
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
AU2020246504B2 (en) * 2019-03-25 2024-02-15 Immunwork Inc. Composite polypeptide having a metal binding motif and molecular construct comprising the same
CN112094824B (zh) * 2020-08-19 2021-04-20 湖北省农业科学院畜牧兽医研究所 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用
CN112458118B (zh) * 2020-11-25 2022-07-26 吉林大学 新流法腺四联病毒样颗粒及其制备方法和应用
CN113521264A (zh) * 2021-07-14 2021-10-22 中国农业科学院北京畜牧兽医研究所 一种鸽球虫病活疫苗及其制备方法和应用
CN114891120B (zh) * 2022-05-08 2022-12-06 青岛海华生物集团股份有限公司 一种二价禽腺病毒特异性抗原融合蛋白
CN114703153B (zh) * 2022-06-06 2022-08-02 广东省农业科学院动物卫生研究所 一株血清2型禽腺病毒毒株以及疫苗和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03505970A (ja) * 1988-07-05 1991-12-26 ジェネックス・コーポレーション 遺伝子工学によるコクシジウム症ワクチン
EP1650310A1 (en) * 1993-04-14 2006-04-26 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
US6296852B1 (en) * 1993-04-14 2001-10-02 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
DE19615803A1 (de) * 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
AU2002316560B2 (en) * 2001-07-06 2008-05-01 Abic Biological Laboratories Ltd Nucleic acids encoding a recombinant 250 kDa antigen from Sporozoites/Merozoites of Eimeria maxima and their uses
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use

Also Published As

Publication number Publication date
US20100150958A1 (en) 2010-06-17
WO2010068968A8 (en) 2010-08-12
HRP20110484A2 (hr) 2011-09-30
TW201026322A (en) 2010-07-16
AU2009328621A1 (en) 2011-07-07
WO2010068968A1 (en) 2010-06-24
AR074679A1 (es) 2011-02-02
IL213061A0 (en) 2011-07-31
KR20110132316A (ko) 2011-12-07
JP2013513548A (ja) 2013-04-22
CA2746310A1 (en) 2010-06-24
BRPI0923513A2 (pt) 2016-01-26
EP2376640A1 (en) 2011-10-19
SG172184A1 (en) 2011-07-28
CN102333877A (zh) 2012-01-25
MX2011006409A (es) 2011-07-12

Similar Documents

Publication Publication Date Title
EA201170812A1 (ru) Способы и композиции для применения вакцины против кокцидиоза
EA200901060A1 (ru) Новый способ и композиции
NZ602278A (en) Bluetongue virus recombinant vaccines and uses thereof
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
EA201492110A1 (ru) Вакцины против впг-2
DE602006019629D1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
EA201001491A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
MX347997B (es) Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle.
MX344103B (es) Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
MX354750B (es) PARTÍCULAS PSEUDO-VIRALES (PPVs) QUE COMPRENDEN GLICOPROTEÍNAS DEL VIRUS DE LA RABIA.
UA108081C2 (uk) Модифікація рекомбінантного аденовірусу імуногенними епітопами білка circumsporozoite плазмодія
NO20090194L (no) Rekombinant viral vaksine
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
ATE461710T1 (de) Nipah-virus-impfstoffe
EA201891945A2 (ru) Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
WO2012021730A3 (en) Respiratory syncytial virus (rsv) vaccine
AR061894A1 (es) Vacunas para malaria
WO2010014567A3 (en) Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
WO2009152147A3 (en) Compositions and methods for dengue virus (dv) treatment and vaccination
EA201291373A1 (ru) Вакцина и способы для устранения инфекции, вызываемой campylobacter
BR112012021650A2 (pt) "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina."
EA201491123A1 (ru) Субъединичная вакцина против цирковируса свиней типа 2 (pcv2)
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
MX354752B (es) Regimen de vacunacion de sensibilizacion y refuerzo heterologo contra malaria.